Remdesivir, the first drug to receive U.S. Food and Drug Administration (FDA) approval for treatment of COVID-19 patients may not improve mortality rates, a new study finds. Read More
Reading Time: < 1 minute Covid-19 hospital admissions in England are continuing to rise, but remain at low levels, as health experts urged eligible people not to…
Reading Time: < 1 minute It is beyond “reasonable doubt” that the Covid-19 pandemic originated in a Chinese animal market, a new scientific study has found. Read More
